Article
3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine
30 Nov 2022
Abstract excerpt
BACKGROUND: Miltefosine treatment failure in visceral leishmaniasis in Brazil has been associated with deletion of the miltefosine susceptibility locus (MSL) in Leishmania infantum. The MSL comprises four genes, 3'-nucleotidase/nucleases (NUC1 and NUC2); helicase-like protein (HLP); and 3,2-trans-enoyl-CoA isomerase (TEI). METHODS: In this study CRISPR-Cas9 was used to either epitope tag or delete NUC1, NUC2, HLP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
